首页> 外文期刊>Chinese journal of cancer >Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation
【24h】

Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation

机译:改进分期系统以提高第八期AJCC / UICC pTNM分期系统对胃腺癌的预后预测性能的建议和验证:一项具有外部验证的多中心研究

获取原文
           

摘要

Background The 8th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) pathological tumor-node-metastasis (pTNM) staging system may have increased accuracy in predicting prognosis of gastric cancer due to its important modifications from previous editions. However, the homogeneity in prognosis within each subgroup classified according to the 8th edition may still exist. This study aimed to compare and analyze the prognosis prediction abilities of the 8th and 7th editions of AJCC/UICC pTNM staging system for gastric cancer and propose a modified pTNM staging system with external validation. Methods In total, clinical data of 7911 patients from three high-capacity institutions in China and 10,208 cases from the Surveillance, Epidemiology, and End Results (SEER) Program Registry were analyzed. The homogeneity, discriminatory ability, and monotonicity of the gradient assessments of the 8th and 7th editions of AJCC/UICC pTNM staging system were compared using log-rank χ2, linear-trend χ2, likelihood-ratio χ2 statistics and Akaike information criterion (AIC) calculations, on which a modified pTNM classification with external validation using the SEER database was proposed. Results Considerable stage migration, mainly for stage III, between the 8th and 7th editions was observed in both cohorts. The survival rates of subgroups of patients within stage IIIA, IIIB, or IIIC classified according to both editions were significantly different, demonstrating poor homogeneity for patient stratification. A modified pTNM staging system using data from the Chinese cohort was then formulated and demonstrated an improved homogeneity in these abovementioned subgroups. This staging system was further validated using data from the SEER cohort, and similar promising results were obtained. Compared with the 8th and 7th editions, the modified pTNM staging system displayed the highest log-rank χ2, linear-trend χ2, likelihood-ratio χ2, and lowest AIC values, indicating its superior discriminatory ability, monotonicity, homogeneity and prognosis prediction ability in both populations. Conclusions The 8th edition of AJCC/UICC pTNM staging system is superior to the 7th edition, but still results in homogeneity in prognosis prediction. Our modified pTNM staging system demonstrated the optimal stratification and prognosis prediction ability in two large cohorts of different gastric cancer populations.
机译:背景技术美国癌症/国际癌症控制联合委员会(AJCC / UICC)病理性肿瘤淋巴结转移(pTNM)分期系统的第8版可能会提高胃癌预后的预测准确性,这是由于其与以往相比有重要的改进版本。但是,根据第8版分类的每个亚组内的预后均一性可能仍然存在。本研究旨在比较和分析第8版和第7版AJCC / UICC pTNM分期系统对胃癌的预后预测能力,并提出一种经过外部验证的改良pTNM分期系统。方法总共分析了来自中国三大医疗机构的7911例患者的临床资料以及来自监测,流行病学和最终结果(SEER)程序注册处的10208例患者的临床资料。使用对数秩χ2,线性趋势χ2,似然比χ2统计和Akaike信息准则(AIC),比较了第8版和第7版AJCC / UICC pTNM分期系统的梯度评估的同质性,区分能力和单调性计算中,提出了使用SEER数据库进行外部验证的改进pTNM分类。结果在两个队列中均观察到了第8版和第7版之间相当大的阶段迁移,主要是III期。根据两个版本分类的IIIA,IIIB或IIIC期患者亚组的生存率显着不同,表明患者分层的同质性较差。然后使用来自中国人群的数据制定了改良的pTNM分期系统,并证明了上述亚组的同质性提高。使用来自SEER队列的数据进一步验证了该分期系统,并获得了类似的有希望的结果。与第8版和第7版相比,改进的pTNM分期系统显示出最高的对数秩χ2,线性趋势χ2,似然比χ2和最低的AIC值,表明其在以下方面具有优越的区分能力,单调性,同质性和预后预测能力两种人群。结论AJCC / UICC pTNM分期系统的第8版优于第7版,但在预后预测方面仍具有同质性。我们改良的pTNM分期系统在两个不同胃癌人群的大型队列中证明了最佳的分层和预后预测能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号